Heart surgery study seeks best way to protect the heart
NCT ID NCT06287372
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study looked at two different methods used to protect the heart during coronary artery bypass surgery. Twenty patients were randomly assigned to receive either Calafiore or modified Del Nido cardioplegic solutions. Researchers measured heart muscle damage markers and amino acid levels during surgery to see which method worked better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- cardioplegic solutions (Calafiore and modified Del Nido)
- What this could lead to
- If successful, this could help surgeons choose the best method to protect the heart during bypass surgery.
- What could go wrong
- This is a very small, completed study with only 20 patients, so results may not apply to everyone. It looks at lab markers, not long-term patient outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC SURGERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Damascus University Cardiac Surgery Hospital
Damascus, Syria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Could continuing a common heart drug before surgery save lives?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?